CHANGJIANG PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.39 CNY | -0.59% |
|
-3.97% | -56.20% |
| May. 08 | Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma | MT |
| Apr. 29 | Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 1.62B 223M | Sales 2023 | 1.2B 165M | Capitalization | 2.71B 374M |
|---|---|---|---|---|---|
| Net income 2022 | -23M -3.17M | Net income 2023 | -606M -83.65M | EV / Sales 2022 | 2.73 x |
| Net Debt 2022 | 1B 138M | Net Debt 2023 | 1.2B 166M | EV / Sales 2023 | 3.27 x |
| P/E ratio 2022 |
-147
x | P/E ratio 2023 |
-4.48
x | Employees | 596 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.46% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.59% | ||
| 1 week | -3.97% | ||
| Current month | -16.30% | ||
| 1 month | -14.61% | ||
| 3 months | -34.17% | ||
| 6 months | -59.50% | ||
| Current year | -56.20% |
1 week
3.28
3.56
1 month
3.284.36
Current year
2.767.97
1 year
2.768.96
3 years
2.7624.00
5 years
2.7624.00
10 years
2.7629.01
| Managers | Title | Age | Since |
|---|---|---|---|
Lu Hong Ning
BRD | Director/Board Member | 53 | 22-07-10 |
Yue Xiao Yang
PRN | Corporate Officer/Principal | 44 | 15-04-30 |
Jin Hui Sun
PRN | Corporate Officer/Principal | 61 | 15-10-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lu Hong Ning
BRD | Director/Board Member | 53 | 22-07-10 |
Jin Hui Sun
PRN | Corporate Officer/Principal | 61 | 15-10-28 |
Yong Xu
BRD | Director/Board Member | 45 | 21-03-28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-27 | 3.39 | -0.59% | 7 497 600 |
| 24-05-27 | 3.41 | +0.59% | 6,452,600 |
| 24-05-24 | 3.39 | +0.59% | 7,105,800 |
| 24-05-23 | 3.37 | -4.80% | 7,932,750 |
| 24-05-22 | 3.54 | +3.51% | 9,741,900 |
End-of-day quote Shenzhen S.E., May 27, 2024
More quotes
Changjiang Pharmaceutical Group Co Ltd, formerly Kangyue Technology Co Ltd, is a China-based company principally engaged in the research and development, production and sales of drugs. The Company is engaged in three businesses. The pharmaceutical business is engaged in traditional Chinese medicine decoction pieces business, medicinal capsule business and pharmaceutical wholesale business. The internal combustion engine parts business is engaged in the research and development, production and sales of turbocharger products. The photovoltaic equipment business is engaged in the research and development, production and sales of photovoltaic equipment such as laminator and stitch welding machine.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -56.20% | 165M | |
| +37.58% | 727B | |
| -7.89% | 354B | |
| +15.61% | 328B | |
| -0.50% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| -6.42% | 203B | |
| +3.83% | 164B | |
| -2.07% | 164B |
- Stock Market
- Equities
- 300391 Stock
